1. Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ . Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer 1991; 49: 650–655.
2. Babiak J, Hugh J, Poppema S . Significance of c-erbB-2 amplification and DNA aneuploidy: analysis in 78 patients with node-negative breast cancer. Cancer 1992; 70: 770–776.
3. Allred DC, Harvey JM, Berardo M, Clark GM . Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155–168.
4. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J . Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998; 58: 2825–2831.
5. Pauletti G, Godolphin W, Press MF, Slamon DJ . Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996; 13: 63–72.